We found that despite identical intracellular SMAD signaling, TGFβ and activin regulate p21 via diverse mechanisms that are functionally relevant in colon cancer leading to more apoptosis or reduction in growth suppression dependent on the activin/TGFβ signaling status with p21 as a differentially regulated target. This evidence concerns the gene CDKN1A and malignant colon neoplasm.